Bioinspired Artificial Nanodecoys for Hepatitis B Virus. 2018

Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102, China.

A facile route is presented for fabricating a new class of nanomimics that overexpress hepatitis B virus (HBV) receptor by a natural biosynthetic procedure against HBV infection. A nine-transmembrane HBV-specific receptor, human sodium taurocholate co-transporting polypeptide (hNTCP), was engineered to naturally immobilize it onto the cellular surface and subsequently trigger the budding of hNTCP-anchoring membrane vesicles (hNTCP-MVs) that favor the HBV virion. hNTCP-MVs could rapidly block HBV infection in cell models. Furthermore, hNTCP-MVs treatment could effectively prevent viral infection, spreading, and replication in a human-liver-chimeric mouse model of HBV infection. Our findings demonstrate the receptor-mediated antiviral effect of hNTCP-MVs to trick HBV and offer novel opportunities for further development of antiviral strategies in nanomedicine.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D049329 Nanostructures Materials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES. Nanomaterials,Nanostructured Materials,Material, Nanostructured,Materials, Nanostructured,Nanomaterial,Nanostructure,Nanostructured Material
D050997 Nanomedicine The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
March 2024, ACS nano,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
February 1987, JAMA,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
May 2010, Autophagy,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
November 2008, Analytical chemistry,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
January 2016, Transplantation proceedings,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
August 2019, Advanced materials (Deerfield Beach, Fla.),
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
November 2002, Nihon rinsho. Japanese journal of clinical medicine,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
January 2007, World journal of gastroenterology,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
March 2024, Bioactive materials,
Xuan Liu, and Lunzhi Yuan, and Liang Zhang, and Yalin Mu, and Xiaoling Li, and Chao Liu, and Peng Lv, and Yali Zhang, and Tong Cheng, and Quan Yuan, and Ningshao Xia, and Xiaoyuan Chen, and Gang Liu
January 1987, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!